Siegfried Holding AG (SWX: SFZN)
Health Care · Life Sciences Tools & Services · CH
CHF67.60
-3.91% today · -17.3% 1Y
Siegfried Holding AG (SWX: SFZN) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $3.71B and employs 4,454 people.
Over the last twelve months the share price has lost 17.3%, trading between 65.05 and 101.60.
Tweenvest scores Siegfried Holding AG across four factors: quality 75/100, value 78/100, growth 78/100, dividend 11/100. Its strongest factor is value.
SFZN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.71B
- Revenue (TTM)
- $1.66B
- P/E
- 18.04
- EPS
- 3.90
- Dividend yield
- 0.58%
- Beta (5Y)
- 0.79
- 52-week high
- CHF101.60
- 52-week low
- CHF65.05
- Avg volume (3M)
- —
- Shares outstanding
- 43.81M
- Employees
- 4,454
- Next earnings
- —
About Siegfried Holding AG
Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
- ISIN
- CH1429326825
- Founded
- 1873
- Listed since
- Apr 3, 1995
- Exchange
- SIX Swiss Exchange
- Currency
- CHF
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SCHOTT Pharma AG & Co. KGaAXTRA: 1SXP | $4.24B | €24.65 | -1.99% |
| Adaptive Biotechnologies CorporationNasdaqGS: ADPT | $4.19B | $26.09 | -0.72% |
| AbCellera Biologics Inc.NasdaqGS: ABCL | $4.16B | $12.02 | -6.31% |
| InSilico Medicine Cayman TopCoSEHK: 3696 | $3.89B | HK$53.00 | -10.62% |
| Tecan Group AGSWX: TECN | $3.44B | CHF229.40 | -0.78% |
| Sai Life Sciences LimitedNSEI: SAILIFE | $3.40B | Rs1,541.20 | -3.20% |
| Shanghai Haoyuan Chemexpress Co., Ltd.SHSE: 688131 | $3.16B | CN¥99.47 | -3.93% |
| Oxford Nanopore Technologies plcLSE: ONT | $2.84B | £2.01 | -8.98% |
Figures last refreshed Oct 4, 2026.